Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYAthenex Announces Expansion of Board of DirectorsPREV STORYBiogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease